Brain cell somatic gene recombination and its phylogenetic foundations

Area of Science:

• Neuroscience
• Genetics
• Molecular Biology

Background:

• Somatic gene recombination (SGR) is a process where gene sequences are altered within an individual's cells.
• The immune system utilizes VDJ recombination, a known form of SGR, with a defined enzymatic pathway.
• The amyloid precursor protein (APP) gene is implicated in Alzheimer's disease.

Purpose of the Study:

• To introduce a newly identified form of SGR in the human brain.
• To explore the mechanisms and evolutionary origins of this brain-specific SGR.
• To discuss the implications of brain SGR in disease and potential therapeutic strategies.

Main Methods:

• Review of existing literature on gene recombination, reverse transcriptase activity, and retrotransposons.
• Analysis of characteristics of newly identified genomic complementary DNAs (gencDNAs) in the brain.
• Comparison of brain SGR with VDJ recombination and other cDNA-like sequences.

Main Results:

• A novel SGR in the human brain produces intron-less genomic complementary DNAs (gencDNAs).
• Brain SGR involves RNA intermediates and reverse transcriptase (RT) activity, similar to retrotransposons.
• gencDNAs are somatic, can be functional, occur in postmitotic cells, and vary with age and disease.

Conclusions:

• Brain SGR may contribute to gene optimization and cellular memory.
• Dysregulation of brain SGR could be involved in neurological disorders, cancer, and other diseases.
• RT inhibitors represent a potential therapeutic approach for SGR-associated conditions.